AuntMinnie

SEPTEMBER 30, 2024

A radiopharmaceutical therapy that lengthens progression-free survival for patients with neuroendocrine cancer could help treat meningioma sufferers, according to research presented at the American Society for Radiation Oncology (ASTRO) meeting. Nearly 80% of patients in our study were progression-free after six months," he said.

Radiation Oncology 119

Radiation Oncology Radiopharmaceuticals Radiation Clinic 119

Imaging Technology

JUNE 12, 2023

The study findings appear online today in JAMA Oncology. “Postoperative SRS is currently the standard of care in these patients, but there is a growing body of research that shows preoperative SRS has advantages,” said Roshan Prabhu, M.D. , The two-year cavity local recurrence rate was 13.7%.

Radiation 98

Radiation Disease Radiation Oncology Ultrasound 98

Imaging Technology

DECEMBER 1, 2023

milla1cf Fri, 12/01/2023 - 13:13 December 1, 2023 — The Radiation Oncology Program at Children’s Hospital Los Angeles is one of only a few in the country to care exclusively for children. The high-dose radiation may attract T-cells, which then go on to kill a much bigger area of the tumor.”

Radiation 105

Radiation Radiation Oncology Clinic Hospital 105

The British Institute of Radiology

MARCH 7, 2023

Radiation oncology clinics face numerous challenges in the present environment, including the simultaneous management of multiple tasks (many of which are manual in nature), various degrees of standardisation, and the potential for errors to impact patient treatment. per week for curative diseases. Healthcare Quarterly.

Radiation Oncology 40

Radiation Oncology Radiation Patient Care Clinic 40

Imaging Technology

APRIL 2, 2024

The availability of these offerings – including the MIM SurePlan and MIM Symphony families, MIM Maestro, MIM Encore, and more – is in alignment with GE HealthCare’s precision care strategy, which aims to deliver innovative digital solutions across care pathways for more precise, connected, and efficient care across disease states. "We

Healthcare 105

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 105

Imaging Technology

OCTOBER 3, 2023

2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA. We could not have achieved these interim clinical results without the support of the doctors and patients who were part of this registry study from across the nation," said Brachman.

Radiation Oncology 122

Radiation Oncology Radiation Medical Device Diagnose 122

AuntMinnie

JUNE 19, 2024

The American Society for Radiation Oncology (ASTRO) has released updated guidelines on the use of radiation therapy in patients with oropharyngeal squamous cell carcinoma (OPSCC) caused by HPV.

Radiation Oncology 59

Radiation Oncology Radiation Disease Diagnose 59

Imaging Technology

NOVEMBER 20, 2023

milla1cf Mon, 11/20/2023 - 12:49 November 20, 2023 — The American Society for Radiation Oncology (ASTRO) issued a clinical guideline on partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ ( DCIS ).

Radiation Oncology 59

Radiation Oncology Clinic Radiation Disease 59

Imaging Technology

SEPTEMBER 27, 2023

milla1cf Wed, 09/27/2023 - 15:07 September 27, 2023 — The American Society for Radiation Oncology ( ASTRO ) announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge.

Radiation Oncology 105

Radiation Oncology Radiation Clinic Disease 105

Imaging Technology

DECEMBER 27, 2023

You can target the proton beam in a highly specific way that results in virtually no damage to the surrounding healthy tissues,” said Arnab Chakravarti , MD, director of the proton therapy center and chair of the Department of Radiation Oncology at OSUCCC – James. Food and Drug Administration.

Radiation Oncology 105

Radiation Oncology Radiation X-ray Hospital 105

Imaging Technology

OCTOBER 1, 2023

Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting. have disparately worse clinical outcomes compared to other racial groups,” said lead study author Alexander J. Allen, MD , a radiation oncology resident physician at the University of Maryland Medical Center in Baltimore.

Radiation Oncology 98

Radiation Oncology Radiation Disease Insurance 98

Imaging Technology

MAY 15, 2023

milla1cf Mon, 05/15/2023 - 10:26 May 15, 2023 — GE HealthCare is presenting three new global innovations – Intelligent Radiation Therapy (iRT), Auto Segmentation, and an updated Magnetic Resonance (MR) Radiation Therapy Suite (AIR Open Coil Suite) – that underscore the company’s commitment to enhancing the radiation oncology care pathway.

Radiation 98

Radiation Radiation Oncology Healthcare Healthcare 98

Imaging Technology

SEPTEMBER 27, 2023

PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. Clinical correlation, which may include histopathological evaluation, is recommended.

Diagnostic 105

Diagnostic Radiation Oncology Radiation Clinic 105

Imaging Technology

OCTOBER 3, 2023

These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the 2023 American Society for Radiation Oncology (ASTRO) Annual Meeting.

Radiation 104

Radiation Computed Tomography Radiation Oncology Magnetic Resonance Imaging 104

AuntMinnie

APRIL 4, 2024

Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. Morris specializes in prostate cancer and new investigational agents. When, in 2022, the U.S.

Nuclear Medicine 88

Nuclear Medicine Radiation Oncology Nursing Radiation 88

AuntMinnie

OCTOBER 2, 2024

Ultrasound model predicts liver disease progression. Assessment of Claimant, Clinical, and Financial Characteristics of Teleradiology Medical Malpractice Cases. Commercially Available Chest Radiograph AI Tools for Detecting Airspace Disease, Pneumothorax, and Pleural Effusion. SPECT/CT reveals heart’s response to tafamidis.

Digital Imaging and Communications in Medicine 144

Digital Imaging and Communications in Medicine X-ray MRI Hospital 144

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology. Chang insists that BAMF Health is not a clinical company.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

Imaging Technology

OCTOBER 2, 2023

Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting. Earlier detection allows for earlier treatment of residual disease and potentially better survival rates. and an estimated 4,000 Americans die from the disease each year. However, the tests are not yet widely available.

Disease 52

Disease Radiation Oncology Radiation Diagnose 52

Imaging Technology

AUGUST 8, 2024

5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved progression-free survival (PFS) in patients with oligometastatic pancreatic cancer. assistant professor of Gastrointestinal Radiation Oncology. “We

Radiation 52

Radiation Radiation Oncology Disease Clinic 52

AuntMinnie

JANUARY 31, 2024

In data from a phase III clinical trial, the investigators found that gallium-68 (Ga-68) PSMA-11 PET initiated major management changes to salvage radiotherapy (RT) planning in 33% of patients – notably, a group for whom the technique was first approved in the U.S.

Radiation 111

Radiation Clinic Disease Radiation Oncology 111

AuntMinnie

JANUARY 26, 2024

Conversely, FAPI radiotracers such as gallium-68 (Ga-68) FAPI have been developed that bind to fibroblast cells in the supportive tissue of tumors, and these PET tracers have shown significant promise for detecting disease in previous studies. PET/CT and MR images of a 72-year-old woman. (A) but presented no evidence for primary tumor.

Nuclear Medicine 122

Nuclear Medicine Imaging MRI Diagnostic 122

Imaging Technology

APRIL 5, 2024

and around the world, with many promising drugs in clinical trials. The generator offers a low-cost alternative for the radiolabeling of biomolecules with Gallium-68 in PET, an imaging examination method used to detect the presence or absence of diseased tissue. The demand for radiopharmaceuticals continues to grow in the U.S.

Radiopharmaceuticals 52

Radiopharmaceuticals Radiation Oncology Radiation Quality and Compliance 52

Imaging Technology

OCTOBER 5, 2023

At the meeting, held from October 1 to October 4, 2023, in San Diego, Simon Powell, MD, PhD, FRCP , Chair of MSK’s Department of Radiation Oncology and Enid A. Haupt Chair in Radiation Oncology, was honored with ASTRO’s Gold Medal Award. It is caused by an inherited mutation in the gene TP53.

Radiation Oncology 52

Radiation Oncology Insurance Radiation Clinic 52

AuntMinnie

DECEMBER 22, 2023

NK/T-cell lymphoma originates from mature T cells and NK cells; while the disease has a low incidence, it progresses rapidly and patients have low survival outcomes, the authors explained. Finally, after the PET/CT scan was done, the patient’s staging was changed from II to IV.

Diagnose 123

Diagnose Hospital Disease Imaging 123

Imaging Technology

OCTOBER 2, 2023

milla1cf Mon, 10/02/2023 - 13:30 October 2, 2023 — A novel liquid biopsy test may help determine which patients with non-small cell lung cancer that has spread beyond the lungs are most likely to benefit from targeted, high-dose radiation, rather than drug-based therapy, a new study suggests. and worldwide. and worldwide. Chaudhuri explained.

Radiation 52

Radiation Radiation Oncology Disease Diagnose 52

Imaging Technology

MAY 2, 2024

One of the biggest challenges of oncology care is the complexity of the disease - both in the many varieties of cancer, and the disparate ways it can present in each individual patient [ii] - requiring diligence and personalization in diagnosis and treatment.

Healthcare 59

Healthcare Healthcare Radiation Oncology Radiation 59

Imaging Technology

OCTOBER 2, 2023

milla1cf Mon, 10/02/2023 - 13:00 October 2, 2023 — A type of head and neck cancer predominantly diagnosed in people who reside in low- and middle-income countries may be treated effectively with fewer, but higher doses of radiation , a large new international study suggests.

Radiation 52

Radiation Radiation Oncology Public Health Diagnose 52

Imaging Technology

OCTOBER 5, 2023

Effective initial staging of prostate cancer, particularly with regards to the detection of metastatic disease, is critical to optimal clinical management of patients,” said Phillip H. Such information can help guide treatment selection and potentially avoid futile surgery for patients with high-risk disease.” “We

Diagnose 52

Diagnose Diagnostic Radiation Disease 52

Imaging Technology

SEPTEMBER 29, 2023

The findings, which are the latest from a series of studies investigating the benefits of stereotactic body radiation therapy (SBRT) for people diagnosed with prostate cancer, will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Radiation 98

Radiation Radiation Oncology Disease Diagnose 98

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman. please insert video here.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52